Published in Viruses on May 13, 2015
Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol (2002) 10.12
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A (1991) 10.05
Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell (2001) 9.08
Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J (2000) 7.48
Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol (1998) 7.27
AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell (2003) 6.69
Exosomes: extracellular organelles important in intercellular communication. J Proteomics (2010) 6.47
Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell (1998) 6.07
The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol (2007) 6.05
Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol (2005) 5.84
Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol (2009) 5.43
A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A (2000) 5.30
The biogenesis and functions of exosomes. Traffic (2002) 4.49
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci U S A (2000) 4.31
A role for ubiquitin ligase recruitment in retrovirus release. Proc Natl Acad Sci U S A (2000) 4.19
Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu Rev Cell Dev Biol (1998) 4.15
Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol (1997) 4.08
Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol (2007) 4.08
Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction. Gene (1994) 3.81
A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature (2013) 3.55
High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One (2009) 3.10
Sorting of proteins into multivesicular bodies: ubiquitin-dependent and -independent targeting. EMBO J (2001) 3.05
Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A (2001) 3.04
WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett (2002) 2.98
Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J Cell Biol (2002) 2.81
Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response. Biochemistry (1997) 2.73
Phosphoinositide signaling and the regulation of membrane trafficking in yeast. Trends Biochem Sci (2000) 2.72
Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J Virol (2001) 2.66
Components of a ubiquitin ligase complex specify polyubiquitination and intracellular trafficking of the general amino acid permease. J Cell Biol (2001) 2.65
Human VPS34 is required for internal vesicle formation within multivesicular endosomes. J Cell Biol (2001) 2.63
HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J Cell Biol (2004) 2.34
Ubiquitin: same molecule, different degradation pathways. Cell (2010) 2.26
Autophagosome supports coxsackievirus B3 replication in host cells. J Virol (2008) 2.24
Functional involvement of a novel Nedd4-like ubiquitin ligase on retrovirus budding. EMBO Rep (2002) 2.22
Ubiquitin recognition by the human TSG101 protein. Mol Cell (2004) 2.17
Location, location, location: membrane targeting directed by PX domains. Science (2001) 2.09
Multivesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity. Curr Biol (1999) 2.00
Context-dependent effects of L domains and ubiquitination on viral budding. J Virol (2004) 1.92
Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J Antibiot (Tokyo) (1991) 1.86
Endosomes, exosomes and Trojan viruses. Trends Microbiol (2004) 1.84
Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts. J Virol (2008) 1.84
Identification and characterization of a novel non-structural protein of bluetongue virus. PLoS Pathog (2011) 1.83
Ubiquitin sorts proteins into the intralumenal degradative compartment of the late-endosome/vacuole. Traffic (2001) 1.79
Virus budding and the ESCRT pathway. Cell Host Microbe (2013) 1.70
Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. J Cell Sci (2004) 1.67
A concentric circle model of multivesicular body cargo sorting. EMBO Rep (2007) 1.65
Late domain-dependent inhibition of equine infectious anemia virus budding. J Virol (2004) 1.57
Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments. Mol Biol Cell (2001) 1.54
Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc Natl Acad Sci U S A (2007) 1.51
Association of hepatitis C virus envelope proteins with exosomes. Eur J Immunol (2004) 1.51
Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics (2009) 1.49
Role of microtubules in extracellular release of poliovirus. J Virol (2009) 1.49
Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins. Mol Biol Cell (2001) 1.47
Tsg101 and Alix interact with murine leukemia virus Gag and cooperate with Nedd4 ubiquitin ligases during budding. J Biol Chem (2005) 1.46
The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release. Proc Natl Acad Sci U S A (2002) 1.42
Characterization of multiple multivesicular body sorting determinants within Sna3: a role for the ubiquitin ligase Rsp5. Mol Biol Cell (2006) 1.42
A viral nonstructural protein regulates bluetongue virus trafficking and release. J Virol (2009) 1.39
Direct binding to Rsp5 mediates ubiquitin-independent sorting of Sna3 via the multivesicular body pathway. Mol Biol Cell (2006) 1.38
Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS Pathog (2014) 1.35
Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic (2008) 1.31
Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol (2006) 1.30
Autophagy hijacked through viroporin-activated calcium/calmodulin-dependent kinase kinase-β signaling is required for rotavirus replication. Proc Natl Acad Sci U S A (2012) 1.30
Uncoating of parental bluetongue virus to core and subcore particles in infected L cells. Virology (1987) 1.29
Bluetongue virus coat protein VP2 contains sialic acid-binding domains, and VP5 resembles enveloped virus fusion proteins. Proc Natl Acad Sci U S A (2010) 1.22
Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes. J Immunol (2009) 1.21
Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies. J Virol (2005) 1.18
Bluetongue virus entry into cells. J Virol (2007) 1.17
Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus. J Virol (1992) 1.14
Localization of the non-structural protein NS3 in bluetongue virus-infected cells. J Gen Virol (1991) 1.13
Bluetongue virus RNA binding protein NS2 is a modulator of viral replication and assembly. BMC Mol Biol (2007) 1.11
Direct binding to Rsp5p regulates ubiquitination-independent vacuolar transport of Sna3p. Mol Biol Cell (2007) 1.11
The release of bluetongue virus from infected cells and their superinfection by progeny virus. Virology (1989) 1.10
Membrane organization of bluetongue virus nonstructural glycoprotein NS3. J Virol (1998) 1.05
Role of multivesicular bodies and their components in the egress of enveloped RNA viruses. Rev Med Virol (2009) 1.04
Interaction of calpactin light chain (S100A10/p11) and a viral NS protein is essential for intracellular trafficking of nonenveloped bluetongue virus. J Virol (2011) 1.01
Bluetongue virus outer capsid protein VP5 interacts with membrane lipid rafts via a SNARE domain. J Virol (2008) 0.99
Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. J Virol (2014) 0.99
Minimum requirements for bluetongue virus primary replication in vivo. J Virol (2012) 0.94
Replication of the rotavirus genome requires an active ubiquitin-proteasome system. J Virol (2011) 0.88
Rotavirus replication requires a functional proteasome for effective assembly of viroplasms. J Virol (2011) 0.87
Viroporin-mediated calcium-activated autophagy. Autophagy (2013) 0.84
Membrane vesicles released by intestinal epithelial cells infected with rotavirus inhibit T-cell function. Viral Immunol (2010) 0.82
Extracellular vesicles containing virus-encoded membrane proteins are a byproduct of infection with modified vaccinia virus Ankara. Virus Res (2008) 0.79
Trafficking of bluetongue virus visualized by recovery of tetracysteine-tagged virion particles. J Virol (2014) 0.79
Pathogenicity study in sheep using reverse-genetics-based reassortant bluetongue viruses. Vet Microbiol (2014) 0.78
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature (2003) 4.60
Bluetongue virus VP4 is an RNA-capping assembly line. Nat Struct Mol Biol (2007) 2.40
Virus-like particles as immunogens. Trends Microbiol (2003) 2.38
Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts. J Virol (2008) 1.84
The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release. Proc Natl Acad Sci U S A (2002) 1.42
Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding. Virol J (2009) 1.39
A viral nonstructural protein regulates bluetongue virus trafficking and release. J Virol (2009) 1.39
Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation. J Virol (2009) 1.37
Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. Virol J (2008) 1.30
Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol (2006) 1.30
Bluetongue virus coat protein VP2 contains sialic acid-binding domains, and VP5 resembles enveloped virus fusion proteins. Proc Natl Acad Sci U S A (2010) 1.22
Interactions between the inner and outer capsids of bluetongue virus. J Virol (2004) 1.22
Purified recombinant bluetongue virus VP1 exhibits RNA replicase activity. J Virol (2004) 1.20
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett (2004) 1.19
Recovery of infectious bluetongue virus from RNA. J Virol (2006) 1.18
Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies. J Virol (2005) 1.18
Bluetongue virus entry into cells. J Virol (2007) 1.17
Bluetongue virus RNA binding protein NS2 is a modulator of viral replication and assembly. BMC Mol Biol (2007) 1.11
Sequence specificity in the interaction of Bluetongue virus non-structural protein 2 (NS2) with viral RNA. J Biol Chem (2003) 1.08
Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress. Virol J (2007) 1.08
Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells. J Virol (2004) 1.07
A capsid protein of nonenveloped Bluetongue virus exhibits membrane fusion activity. Proc Natl Acad Sci U S A (2004) 1.07
Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release. J Virol (2004) 1.06
Defining the structure-function relationships of bluetongue virus helicase protein VP6. J Virol (2003) 1.03
Interaction of calpactin light chain (S100A10/p11) and a viral NS protein is essential for intracellular trafficking of nonenveloped bluetongue virus. J Virol (2011) 1.01
In vitro reconstitution of Bluetongue virus infectious cores. Proc Natl Acad Sci U S A (2011) 0.99
Bluetongue virus outer capsid protein VP5 interacts with membrane lipid rafts via a SNARE domain. J Virol (2008) 0.99
Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesis. Virol J (2012) 0.98
Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge. J Virol (2011) 0.97
Specific binding of Bluetongue virus NS2 to different viral plus-strand RNAs. Virology (2006) 0.96
Minimum requirements for bluetongue virus primary replication in vivo. J Virol (2012) 0.94
A reverse genetics system of African horse sickness virus reveals existence of primary replication. FEBS Lett (2010) 0.93
The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathway. J Virol (2012) 0.92
Reconstitution of bluetongue virus polymerase activity from isolated domains based on a three-dimensional structural model. Biopolymers (2007) 0.92
Mapping the assembly pathway of Bluetongue virus scaffolding protein VP3. Virology (2004) 0.90
Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen. J Virol (2005) 0.88
Virus-derived tubular structure displaying foreign sequences on the surface elicit CD4+ Th cell and protective humoral responses. Virology (2002) 0.88
Assembly and intracellular localization of the bluetongue virus core protein VP3. J Virol (2005) 0.87
Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences. Vaccine (2002) 0.87
Multigene expression of protein complexes by iterative modification of genomic Bacmid DNA. BMC Mol Biol (2009) 0.86
Role of lipids on entry and exit of bluetongue virus, a complex non-enveloped virus. Viruses (2010) 0.86
Role of cellular caspases, nuclear factor-kappa B and interferon regulatory factors in Bluetongue virus infection and cell fate. Virol J (2010) 0.86
Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes. Vaccine (2002) 0.85
Rotavirus mRNAS are released by transcript-specific channels in the double-layered viral capsid. Proc Natl Acad Sci U S A (2013) 0.84
Rehosting of bacterial chaperones for high-quality protein production. Appl Environ Microbiol (2009) 0.84
Recovery of African horse sickness virus from synthetic RNA. J Gen Virol (2013) 0.84
Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep. J Virol (2013) 0.84
Bluetongue virus VP1 polymerase activity in vitro: template dependency, dinucleotide priming and cap dependency. PLoS One (2011) 0.83
Assembly of feline calicivirus-like particle and its immunogenicity. Vet Microbiol (2006) 0.83
Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep. PLoS One (2011) 0.83
Cellular phosphoinositides and the maturation of bluetongue virus, a non-enveloped capsid virus. Virol J (2013) 0.81
Modeling rotavirus-like particles production in a baculovirus expression vector system: Infection kinetics, baculovirus DNA replication, mRNA synthesis and protein production. J Biotechnol (2007) 0.81
Multiple large foreign protein expression by a single recombinant baculovirus: a system for production of multivalent vaccines. Protein Expr Purif (2013) 0.80
Bluetongue virus infection alters the impedance of monolayers of bovine endothelial cells as a result of cell death. Vet Immunol Immunopathol (2010) 0.80
Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen. Vaccine (2012) 0.80
Immunization against active ghrelin using virus-like particles for obesity treatment. Curr Pharm Des (2013) 0.80
Intermolecular interactions in a two-layered viral capsid that requires a complex symmetry mismatch. J Virol (2003) 0.78
Baculovirus solves a complex problem. Nat Biotechnol (2004) 0.76
Comparative analysis of the roles of simian immunodeficiency and bovine leukemia virus matrix proteins in Gag assembly in insect cells. Virology (2002) 0.75
Manipulation of the bluetongue virus tubules for immunogen delivery. Future Microbiol (2008) 0.75